NGFR and prostate carcinoma: tested 30 million compounds in silico and found that carprofen activates the p38 mitogen‐activated protein kinase (MAPK) leading to an increased level of the p75NTR protein and the induction of apoptosis in prostate cancer cells (PC‐3 and DU‐145) and urinary bladder (T24).